English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Tempus Labs
Patient Daily
| May 7, 2023
Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
Patient Daily
| Apr 24, 2023
Tempus Announces Seven Abstracts Accepted For Presentation at the American Association for Cancer Research Annual Meeting 2023
Patient Daily Report
| Apr 13, 2023
Tempus Announces Seven Abstracts Accepted For Presentation at the American Association for Cancer Research Annual Meeting 2023
Trending
Patient Daily
| Oct 23, 2025
Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+
Pharmaceuticals
Patient Daily
| Oct 23, 2025
Empower seeks dismissal of Eli Lilly suit in Texas federal court
+
Pharmaceuticals
Patient Daily
| Oct 29, 2025
Paragon Health Institute senior fellow: 340B program 'needs real reform'
